← Back

Jeito Capital

vc$1.2BCo-investsLeads rounds

Fund Size

$1.2B

Check Size

$75.0M$150.0M

Location

France

Activity

Statusactively investing

Links

Share this fund

Investment Thesis

Jeito’s investment thesis is centered on financing and accelerating breakthrough biopharma innovation from clinical development through market access, with an emphasis on companies that can become leaders in therapeutic areas with substantial unmet medical need. The firm appears to favor clinical-stage opportunities primarily in Europe, while also supporting growth of portfolio companies in the United States, and it allocates large amounts of capital per company to help advance assets through the expensive late-stage drug development path.[1][3][4][7]

About Jeito Capital

Jeito Capital is a Paris-based, fully independent life sciences investor focused on biopharma and innovative medical companies. It backs clinical-stage companies developing breakthrough therapies for severe diseases with high unmet medical need, and it typically provides significant follow-on capital plus operational support through development and commercialization.[4][7]

Sectors

Biotech

Stages

series-aseries-bseries-c

Geography Focus

EuropeGlobalUnited States

Team

NameTitleRoleLinks
Chloé RocheAnalystin
Daniel WollePrincipalin
Elana LockshinAnalystin
Ivana TrivunovicAnalystin
Julien ElricSenior Principalin𝕏
Ksenija PavleticGeneral Partner & Chief Commercial Officerin
Maya ChkaibanPrincipalin
Mehdi AinouchePartnerin
Noémie TimsitAssociate
Pascal TouchonOperating Partner
Rafaèle TordjmanFounder & CEOin
Sabine DandiguianManaging Partnerin

Notable Investments

nullPulmocideSparingVisionBionyra PharmaAdcendo ApSCatalYm

Traits

Leads rounds

Co-invests

FAQ

What does Jeito Capital invest in?

Jeito Capital invests in Biotech at the series-a, series-b and series-c stages.

Which geographies does Jeito Capital focus on?

Jeito Capital focuses on Europe, Global and United States, and is headquartered in France.

What is Jeito Capital's typical check size?

Jeito Capital typically writes checks of $75M to $150M.